Plasma cell leukemia (PCL) is a rare disease that may ... lenalidomide and transplant-based regimens will probably improve treatment outcome. There is insufficient information to support ...

Thanks to new treatments, people with refractory multiple myeloma have more options and may live longer. In multiple myeloma, abnormal plasma cells multiply in your bone marrow — the soft ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

This condition can affect many areas of the body, but around 80% of cases involve the skin, according to the Leukemia and ... destroy the cancerous cells. This and other treatments can have ...

For many decades, the foundations of cancer treatment have been surgery, chemotherapy, and radiation therapy. But, in recent years, a newer therapy in the form of immunotherapy has emerged, ...